ArticleInternational journal of cancer2020

IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancer.

Dinja T Kruger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.